TREATMENTS &
RESEARCH

Search the
latest
treatment
information
here.

Dr. Huntley's
Diagnosis
Checklist

Have a symptom?
See what questions
a doctor would ask.
 
Articles » NINDS von Hippel-Lindau Disease Information Page: NINDS
 

NINDS von Hippel-Lindau Disease Information Page: NINDS

Article title: NINDS von Hippel-Lindau Disease Information Page: NINDS

Main condition: von Hippel-Lindau disease

Conditions: von Hippel-Lindau disease


Table of Contents (click to jump to sections)What is von Hippel-Lindau disease (VHL)?
Is there any treatment?
What is the prognosis?
What research is being done?

Selected references
Organizations

What is von Hippel-Lindau disease (VHL)?
von Hippel-Lindau disease (VHL) is a rare, genetic multi-system disorder characterized by the abnormal growth of tumors in certain parts of the body (angiomatosis). The tumors of the central nervous system (CNS) are benign and are comprised of a nest of blood vessels and are called hemangioblastomas (or angiomas in the eye). Hemangioblastomas may develop in the brain, the retina of the eyes, and other areas of the nervous system. Other types of tumors develop in the adrenal glands, the kidneys, or the pancreas. Symptoms of VHL vary among patients and depend on the size and location of the tumors. Symptoms may include headaches, problems with balance and walking, dizziness, weakness of the limbs, vision problems, and high blood pressure. Cysts (fluid-filled sacs) and/or tumors (benign or cancerous) may develop around the angiomas and cause the symptoms listed above. Individuals with VHL are also at a higher risk than normal for certain types of cancer, especially kidney cancer.

Is there any treatment?
Treatment for VHL varies according to the location and size of the angiomas. In general, the objective of treatment is to treat the growths when they are small so that they do not cause permanent problems by putting pressure on the brain or spine, blocking the flow of cerebrospinal fluid in the nervous system, or impairing vision. Treatment of most cases of VHL usually involves surgery to remove the tumors before they become harmful. Certain tumors can be treated with focused high-dose irradiation. Individuals with VHL need careful monitoring by a physician and/or medical team familiar with the disorder.

What is the prognosis?
The prognosis for patients with VHL depends on the location and complications of the tumors. Untreated, VHL may result in blindness and/or permanent brain damage. With early detection and treatment the prognosis is significantly improved. Death is usually caused by complications of brain tumors or kidney cancer.

What research is being done?
The NINDS pursues a vigorous program of research aimed at preventing and treating disorders that cause tumors in the brain and spinal cord such as VHL.

Selected references

Bradley, W, et al (eds).
Neurology in Clinical Practice: Principles of Diagnosis and Management, vol. II Butterworth-Heinemann, Boston, pp. 1332-1333 (1991)

Joynt, R (ed.)
Clinical Neurology, vol. 3 J.B. Lippincott Co., Philadelphia, pp. 7, 39, 83 (1992)

Karsdorp, N, et al.
von Hippel-Lindau Disease: New Strategies in Early Detection and Treatment. The American Journal of Medicine 97; 158-168 (August 1994)

Lesho, E.
Recognition and Management of von Hippel-Lindau Disease. American Family Physician 50:6; 1269-1272 (November 1, 1994)

Martz, C.
von Hippel-Lindau Disease: A Genetic Condition Predisposing Tumor Formation. Oncology Nursing Forum 18:3; 545-551 (1991)

 Organizations

Genetic Alliance
4301 Connecticut Avenue, N.W.
Suite 404
Washington, DC 20008-2304
info@geneticalliance.org
http://www.geneticalliance.org/
Tel: 202-966-5557 800 336-GENE  (4363)
Fax: 202-966-8553

National Organization for Rare Disorders (NORD)
P.O. Box 8923
(100 Route 37)
New Fairfield, CT 06812-8923
orphan@rarediseases.org
http://www.rarediseases.org/
Tel: 203-746-6518 800-999-NORD (6673)
Fax: 203-746-6481

Von Hippel Lindau Family Alliance
171 Clinton Road
Brookline, MA 02445
info@vhl.org
http://www.vhl.org/
Tel: 617-277-5667 800-767-4VHL (4845)
Fax: 617-734-8233

This fact sheet is in the public domain. You may copy it.Provided by:
The National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, MD 20892


Return to top



Home | About NINDS | Disorders | Funding | News & Events | Find People | Jobs & Training | Accessibility

 » Next page: NINDS Wallenberg's Syndrome Information Page: NINDS

Rate This Website

What do you think about the features of this website? Take our user survey and have your say:

Website User Survey

Medical Tools & Articles:

Tools & Services:

Medical Articles:

Forums & Message Boards

 
HONcode We subscribe to the HONcode principles

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise